Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma

Abstract Mepolizumab (anti-IL5 therapy) reduces asthma exacerbations in urban children with exacerbation-prone eosinophilic asthma. We previously utilized nasal transcriptomics to identify inflammatory pathways (gene co-expression modules) associated with asthma exacerbations despite this therapy. I...

詳細記述

書誌詳細
出版年:Nature Communications
主要な著者: Courtney L. Gaberino, R. Max Segnitz, Kimberly A. Dill-McFarland, Leonard B. Bacharier, Agustin Calatroni, Michelle A. Gill, Jeffrey Stokes, Andrew H. Liu, Robyn T. Cohen, Rajesh Kumar, Abigail Lang, Gurjit K. Khurana Hershey, Michael G. Sherenian, Edward M. Zoratti, Stephen J. Teach, Meyer Kattan, Patrice M. Becker, Alkis Togias, William W. Busse, Daniel J. Jackson, Matthew C. Altman
フォーマット: 論文
言語:英語
出版事項: Nature Portfolio 2025-09-01
オンライン・アクセス:https://doi.org/10.1038/s41467-025-63629-2
_version_ 1849290474682056704
author Courtney L. Gaberino
R. Max Segnitz
Kimberly A. Dill-McFarland
Leonard B. Bacharier
Agustin Calatroni
Michelle A. Gill
Jeffrey Stokes
Andrew H. Liu
Robyn T. Cohen
Rajesh Kumar
Abigail Lang
Gurjit K. Khurana Hershey
Michael G. Sherenian
Edward M. Zoratti
Stephen J. Teach
Meyer Kattan
Patrice M. Becker
Alkis Togias
William W. Busse
Daniel J. Jackson
Matthew C. Altman
author_facet Courtney L. Gaberino
R. Max Segnitz
Kimberly A. Dill-McFarland
Leonard B. Bacharier
Agustin Calatroni
Michelle A. Gill
Jeffrey Stokes
Andrew H. Liu
Robyn T. Cohen
Rajesh Kumar
Abigail Lang
Gurjit K. Khurana Hershey
Michael G. Sherenian
Edward M. Zoratti
Stephen J. Teach
Meyer Kattan
Patrice M. Becker
Alkis Togias
William W. Busse
Daniel J. Jackson
Matthew C. Altman
author_sort Courtney L. Gaberino
collection DOAJ
container_title Nature Communications
description Abstract Mepolizumab (anti-IL5 therapy) reduces asthma exacerbations in urban children with exacerbation-prone eosinophilic asthma. We previously utilized nasal transcriptomics to identify inflammatory pathways (gene co-expression modules) associated with asthma exacerbations despite this therapy. In this study, we applied differential gene correlation analysis on these targeted gene co-expression modules to gain better insight into the treatment effects on correlation structure within gene networks. Mepolizumab treatment resulted in loss of correlation amongst eosinophil-specific genes but conservation and even strengthening of correlation amongst mast cell-specific genes, T2 cytokines, and airway epithelial inflammatory genes. Notably, mepolizumab induced significant gain in correlation of genes associated with multiple aspects of airway epithelial inflammation including those related to extracellular matrix production and nitric oxide synthesis, and this change was associated with a poor clinical response to mepolizumab. These findings highlight that using differential gene correlation analysis offers insight into the molecular regulatory effects of treatment on gene interactions and may lead to better understanding of disease mechanisms and therapeutic responses. ClinicalTrials.gov ID: NCT03292588.
format Article
id doaj-art-b72fcb02eb9e4ba088b1e53d04fcdbee
institution Directory of Open Access Journals
issn 2041-1723
language English
publishDate 2025-09-01
publisher Nature Portfolio
record_format Article
spelling doaj-art-b72fcb02eb9e4ba088b1e53d04fcdbee2025-09-07T11:24:10ZengNature PortfolioNature Communications2041-17232025-09-0116111610.1038/s41467-025-63629-2Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthmaCourtney L. Gaberino0R. Max Segnitz1Kimberly A. Dill-McFarland2Leonard B. Bacharier3Agustin Calatroni4Michelle A. Gill5Jeffrey Stokes6Andrew H. Liu7Robyn T. Cohen8Rajesh Kumar9Abigail Lang10Gurjit K. Khurana Hershey11Michael G. Sherenian12Edward M. Zoratti13Stephen J. Teach14Meyer Kattan15Patrice M. Becker16Alkis Togias17William W. Busse18Daniel J. Jackson19Matthew C. Altman20Department of Pediatrics, University of Wisconsin School of Medicine and Public HealthDepartment of Medicine, University of WashingtonDepartment of Medicine, University of WashingtonDepartment of Pediatrics, Monroe Carell Jr. Children’s Hospital at VanderbiltRho IncDepartment of Pediatrics, Washington UniversityDepartment of Pediatrics, Washington UniversityDepartment of Pediatrics, Children’s Hospital Colorado, University of Colorado School of MedicineDepartment of Pediatrics, Boston University School of MedicineDepartment of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of ChicagoDepartment of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of ChicagoDepartment of Pediatrics, Cincinnati Children’s HospitalDepartment of Pediatrics, Cincinnati Children’s HospitalDepartment of Medicine, Henry Ford Health SystemChildren’s National HospitalDepartment of Pediatrics, Columbia UniversityNational Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Institute of Allergy and Infectious Diseases, National Institutes of HealthDepartment of Pediatrics, University of Wisconsin School of Medicine and Public HealthDepartment of Pediatrics, University of Wisconsin School of Medicine and Public HealthDepartment of Medicine, University of WashingtonAbstract Mepolizumab (anti-IL5 therapy) reduces asthma exacerbations in urban children with exacerbation-prone eosinophilic asthma. We previously utilized nasal transcriptomics to identify inflammatory pathways (gene co-expression modules) associated with asthma exacerbations despite this therapy. In this study, we applied differential gene correlation analysis on these targeted gene co-expression modules to gain better insight into the treatment effects on correlation structure within gene networks. Mepolizumab treatment resulted in loss of correlation amongst eosinophil-specific genes but conservation and even strengthening of correlation amongst mast cell-specific genes, T2 cytokines, and airway epithelial inflammatory genes. Notably, mepolizumab induced significant gain in correlation of genes associated with multiple aspects of airway epithelial inflammation including those related to extracellular matrix production and nitric oxide synthesis, and this change was associated with a poor clinical response to mepolizumab. These findings highlight that using differential gene correlation analysis offers insight into the molecular regulatory effects of treatment on gene interactions and may lead to better understanding of disease mechanisms and therapeutic responses. ClinicalTrials.gov ID: NCT03292588.https://doi.org/10.1038/s41467-025-63629-2
spellingShingle Courtney L. Gaberino
R. Max Segnitz
Kimberly A. Dill-McFarland
Leonard B. Bacharier
Agustin Calatroni
Michelle A. Gill
Jeffrey Stokes
Andrew H. Liu
Robyn T. Cohen
Rajesh Kumar
Abigail Lang
Gurjit K. Khurana Hershey
Michael G. Sherenian
Edward M. Zoratti
Stephen J. Teach
Meyer Kattan
Patrice M. Becker
Alkis Togias
William W. Busse
Daniel J. Jackson
Matthew C. Altman
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title_full Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title_fullStr Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title_full_unstemmed Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title_short Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
title_sort mepolizumab alters gene regulatory networks of nasal airway type 2 and epithelial inflammation in urban children with asthma
url https://doi.org/10.1038/s41467-025-63629-2
work_keys_str_mv AT courtneylgaberino mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT rmaxsegnitz mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT kimberlyadillmcfarland mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT leonardbbacharier mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT agustincalatroni mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT michelleagill mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT jeffreystokes mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT andrewhliu mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT robyntcohen mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT rajeshkumar mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT abigaillang mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT gurjitkkhuranahershey mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT michaelgsherenian mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT edwardmzoratti mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT stephenjteach mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT meyerkattan mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT patricembecker mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT alkistogias mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT williamwbusse mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT danieljjackson mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma
AT matthewcaltman mepolizumabaltersgeneregulatorynetworksofnasalairwaytype2andepithelialinflammationinurbanchildrenwithasthma